Back to search

Article

SCD5 Expression Correlates with Prognosis and Response to Neoadjuvant Chemotherapy in Breast Cancer

2020-12-10

Abstract excerpt

Neoadjuvant chemotherapy (NACT) represents a standard option for breast cancer. Unfortunately, about 55% to 80% of breast cancer patients do not have a favorable response to chemotherapy. Highly specific tumor biomarker that can predict the pathological response to neoadjuvant chemotherapy is lacking. Stearoyl-CoA desaturase 5 (SCD5) is an integral membrane protein of the endoplasmic reticulum that participates in...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
291ad7e8-1f44-5fc3-845c-657a266527ae
DOI
10.21203/rs.3.rs-117096/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
SCD5 Expression Correlates with Prognosis and Response to Neoadjuvant Chemotherapy in Breast CancerDOI 10.21203/rs.3.rs-117096/v1
Investigating the role of FADS family members in breast cancer based on bioinformatic analysis and experimental validationSemantic proximity
Transcriptomic analysis identified new lipid biomarkers for patient stratification in breast cancerSemantic proximity
Systematic analysis of fatty acid desaturases in breast invasive carcinoma: The prognosis, gene mutation, and tumor immune microenvironment.Semantic proximity
Decoding the Tumor-Suppressive Landscape of SCARA5: A Network-Based Analysis Linking Lipid Metabolism and Immune Regulation in Breast CancerSemantic proximity
Over-expression of SRD5A3 and its prognostic significance in breast cancerSemantic proximity
Systematic analysis of ZDHHC9 as a potential prognostic and immunotherapy biomarker in breast cancerSemantic proximity
HDHD5 promotes triple-negative breast cancer growth and drives EMT-associated phenotypes via regulating S100A4.Semantic proximity
DLGAP5 Regulates the Proliferation, Migration, Invasion, and Cell Cycle of Breast Cancer Cells via the JAK2/STAT3 Signaling AxisSemantic proximity
Integrating Single-cell and Machine Learning with Experimental Validation Reveals FASN Conferring Breast Cancer Stem cell-like Properties: Therapeutic Insights and Prognostic ImplicationsSemantic proximity
Identification and validation of DHCR7 as a diagnostic biomarker involved in the proliferation and mitochondrial function of breast cancerSemantic proximity
Mechanistic and Clinical Evidence Supports a Key Role for Cell Division Cycle Associated 5 (CDCA5) as an Independent Predictor of Outcome in Invasive Breast CancerSemantic proximity
Exploring the critical role of SDHA in breast cancer proliferation: implications for novel therapeutic strategiesSemantic proximity
Select a neighboring publication to make it the new centre.